BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Caccia S. Safety and Pharmacokinetics of Atypical Antipsychotics in Children and Adolescents. Pediatr Drugs 2013;15:217-33. [DOI: 10.1007/s40272-013-0024-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Hutchins LM, Shipman A, Zimmerman KO, Heath TS. Evaluation of QTc Interval Effects of Antipsychotic Medications for Intensive Care Unit Delirium in Pediatric Patients. J Pediatr Pharmacol Ther 2021;26:87-91. [PMID: 33424505 DOI: 10.5863/1551-6776-26.1.87] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chan HW, Huang CY, Feng WJ, Yen YC. Risperidone long-acting injection and 1-year rehospitalization rate of schizophrenia patients: A retrospective cohort study. Psychiatry Clin Neurosci 2015;69:497-503. [PMID: 25781185 DOI: 10.1111/pcn.12294] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 Shedlock K, Susi A, Gorman GH, Hisle-Gorman E, Erdie-Lalena CR, Nylund CM. Autism Spectrum Disorders and Metabolic Complications of Obesity. J Pediatr 2016;178:183-187.e1. [PMID: 27592097 DOI: 10.1016/j.jpeds.2016.07.055] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 6.6] [Reference Citation Analysis]
4 Pan B, Lian J, Deng C. Chronic antipsychotic treatment differentially modulates protein kinase A- and glycogen synthase kinase 3 beta-dependent signaling pathways, N-methyl-D-aspartate receptor and γ-aminobutyric acid A receptors in nucleus accumbens of juvenile rats. J Psychopharmacol 2018;32:1252-63. [PMID: 30136620 DOI: 10.1177/0269881118788822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lian J, Pan B, Deng C. Early antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile rats. Pharmacol Rep 2016;68:1028-35. [PMID: 27428765 DOI: 10.1016/j.pharep.2016.06.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
6 Cicala G, Barbieri MA, Santoro V, Tata C, Colucci PV, Vanadia F, Drago F, Russo C, Cutroneo PM, Gagliano A, Spina E, Germanò E. Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study. Front Psychiatry 2020;11:152. [PMID: 32265749 DOI: 10.3389/fpsyt.2020.00152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Joyce C, Witcher R, Herrup E, Kaur S, Mendez-Rico E, Silver G, Greenwald BM, Traube C. Evaluation of the Safety of Quetiapine in Treating Delirium in Critically Ill Children: A Retrospective Review. J Child Adolesc Psychopharmacol 2015;25:666-70. [PMID: 26469214 DOI: 10.1089/cap.2015.0093] [Cited by in Crossref: 47] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
8 Sylvester E, Yi W, Han M, Deng C. Exercise intervention for preventing risperidone-induced dyslipidemia and gluco-metabolic disorders in female juvenile rats. Pharmacol Biochem Behav 2020;199:173064. [PMID: 33127383 DOI: 10.1016/j.pbb.2020.173064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Germanò E, Italiano D, Lamberti M, Guerriero L, Privitera C, D'Amico G, Siracusano R, Ingrassia M, Spina E, Calabrò MP, Gagliano A. ECG parameters in children and adolescents treated with aripiprazole and risperidone. Prog Neuropsychopharmacol Biol Psychiatry 2014;51:23-7. [PMID: 24211841 DOI: 10.1016/j.pnpbp.2013.10.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
10 Zhu M, Ferrara M, Tan W, Shang X, Syed S, Zhang L, Qin Q, Hu X, Rohrbaugh R, Srihari VH, Liu Z. Drug-naïve first-episode schizophrenia spectrum disorders: Pharmacological treatment practices in inpatient units in Hunan Province, China. Early Interv Psychiatry 2021;15:1010-8. [PMID: 32924286 DOI: 10.1111/eip.13046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Kolarich AR, Mubarak M, Wells S, Campbell CT, Samraj RS. A case of sinus pause induced by swallowing in the setting of olanzapine and guanfacine overdose. J Intensive Care Soc 2019;20:277-80. [PMID: 31447925 DOI: 10.1177/1751143718786109] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Wijma RA, van der Nagel BC, Dierckx B, Dieleman GC, Touw DJ, van Gelder T, Koch BC. Identification and quantification of the antipsychotics risperidone, aripiprazole, pipamperone and their major metabolites in plasma using ultra-high performance liquid chromatography-mass spectrometry. Biomed Chromatogr 2016;30:794-801. [PMID: 26447610 DOI: 10.1002/bmc.3610] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
13 Pozzi M, Cattaneo D, Baldelli S, Fucile S, Capuano A, Bravaccio C, Sportiello L, Bertella S, Auricchio F, Bernardini R, Ferrajolo C, Guastella G, Mani E, Carnovale C, Pisano S, Rafaniello C, Riccio MP, Rizzo R, Scuderi MG, Sperandeo S, Villa L, Pascotto A, Molteni M, Rossi F, Radice S, Clementi E. Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings. Eur J Clin Pharmacol 2016;72:285-93. [DOI: 10.1007/s00228-015-1982-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
14 Varimo E, Aronen ET, Mogk H, Rättö H, Saastamoinen LK. Antipsychotic Treatment Duration in Children and Adolescents: A Register-Based Nationwide Study. J Child Adolesc Psychopharmacol 2021;31:421-9. [PMID: 33739863 DOI: 10.1089/cap.2020.0095] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Sugimoto Y, Yamamura K, Takayama T, Fukuta Y, Aoki K, Mikami K, Tomoda A. Aripiprazole in the real-world treatment for irritability associated with autism spectrum disorder in children and adolescents in Japan: 52-week post-marketing surveillance. BMC Psychiatry 2021;21:204. [PMID: 33888067 DOI: 10.1186/s12888-021-03201-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Gupta M, Hoover G Jr. Lurasidone an Effective Alternative for the Treatment of Irritability Associated With Autism Spectrum Disorder. Cureus 2020;12:e12360. [PMID: 33520554 DOI: 10.7759/cureus.12360] [Reference Citation Analysis]
17 Pisano S, Catone G, Veltri S, Lanzara V, Pozzi M, Clementi E, Iuliano R, Riccio MP, Radice S, Molteni M, Capuano A, Gritti A, Coppola G, Milone A, Bravaccio C, Masi G. Update on the safety of second generation antipsychotics in youths: a call for collaboration among paediatricians and child psychiatrists. Ital J Pediatr 2016;42:51. [PMID: 27209326 DOI: 10.1186/s13052-016-0259-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
18 Rafaniello C, Pozzi M, Pisano S, Ferrajolo C, Bertella S, Sportiello L, Carnovale C, Sullo MG, Cattaneo D, Gentili M, Rizzo R, Pascotto A, Mani E, Villa L, Riccio MP, Sperandeo S, Bernardini R, Bravaccio C, Clementi E, Molteni M, Rossi F, Radice S, Capuano A. Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switch. Expert Opin Drug Saf 2016;15:1-8. [PMID: 27875914 DOI: 10.1080/14740338.2016.1229301] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
19 Sung M, Chin CH, Lim CG, Liew HS, Lim CS, Kashala E, Weng SJ. What's in the pipeline? Drugs in development for autism spectrum disorder. Neuropsychiatr Dis Treat 2014;10:371-81. [PMID: 24591832 DOI: 10.2147/NDT.S39516] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
20 Kuang H, Johnson JA, Mulqueen JM, Bloch MH. The efficacy of benzodiazepines as acute anxiolytics in children: A meta-analysis. Depress Anxiety 2017;34:888-96. [PMID: 28504861 DOI: 10.1002/da.22643] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Varimo E, Saastamoinen LK, Rättö H, Mogk H, Aronen ET. New Users of Antipsychotics Among Children and Adolescents in 2008-2017: A Nationwide Register Study. Front Psychiatry 2020;11:316. [PMID: 32390885 DOI: 10.3389/fpsyt.2020.00316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
22 Krill RA, Kumra S. Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management. Adolesc Health Med Ther 2014;5:171-82. [PMID: 25298741 DOI: 10.2147/AHMT.S49807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
23 Tron C, Kloosterboer SM, van der Nagel BCH, Wijma RA, Dierckx B, Dieleman GC, van Gelder T, Koch BCP. Dried Blood Spots Combined With Ultra-High-Performance Liquid Chromatography-Mass Spectrometry for the Quantification of the Antipsychotics Risperidone, Aripiprazole, Pipamperone, and Their Major Metabolites. Ther Drug Monit 2017;39:429-40. [PMID: 28700523 DOI: 10.1097/FTD.0000000000000411] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
24 Campbell CT, Grey E, Munoz-Pareja J, Manasco KB. An Evaluation of Risperidone Dosing for Pediatric Delirium in Children Less Than or Equal to 2 Years of Age. Ann Pharmacother 2020;54:464-9. [PMID: 31771334 DOI: 10.1177/1060028019891969] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
25 McLaren JL, Barnett ER, Concepcion Zayas MT, Lichtenstein J, Acquilano SC, Schwartz LM, Woloshin S, Drake RE. Psychotropic medications for highly vulnerable children. Expert Opin Pharmacother 2018;19:547-60. [PMID: 29596008 DOI: 10.1080/14656566.2018.1445720] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
26 Kaguelidou F, Acquaviva E. Safety of Psychotropic Drugs in Children and Adolescents. In: Spina E, Trifirò G, editors. Pharmacovigilance in Psychiatry. Cham: Springer International Publishing; 2016. pp. 257-83. [DOI: 10.1007/978-3-319-24741-0_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Lian J, De Santis M, He M, Deng C. Risperidone-induced weight gain and reduced locomotor activity in juvenile female rats: The role of histaminergic and NPY pathways. Pharmacological Research 2015;95-96:20-6. [DOI: 10.1016/j.phrs.2015.03.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
28 Jovanović M, Vučićević K, Miljković B. Understanding variability in the pharmacokinetics of atypical antipsychotics - focus on clozapine, olanzapine and aripiprazole population models. Drug Metab Rev 2020;52:1-18. [PMID: 32008418 DOI: 10.1080/03602532.2020.1717517] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
29 Whitney Z, Boyda HN, Procyshyn RM, Elbe D, Black T, Eslami A, Barr AM. Therapeutic Drug Levels of Second Generation Antipsychotics in Youth: A Systematic Review. Journal of Child and Adolescent Psychopharmacology 2015;25:234-45. [DOI: 10.1089/cap.2014.0044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
30 Liu X, Feng X, Deng C, Liu L, Zeng Y, Hu CH. Brown adipose tissue activity is modulated in olanzapine-treated young rats by simvastatin. BMC Pharmacol Toxicol 2020;21:48. [PMID: 32605639 DOI: 10.1186/s40360-020-00427-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Matsumoto H, Ishigooka J, Ono H, Tadori Y. Safety and efficacy from a 6-week double-blind study and a 52-week open-label extension of aripiprazole in adolescents with schizophrenia in Japan: Aripiprazole for schizophrenia. Psychiatry Clin Neurosci 2018;72:701-12. [DOI: 10.1111/pcn.12681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 de la Torre Villalobos M, Martin-López LM, Fernández Sanmartín MI, Pujals Altes E, Gasque Llopis S, Batlle Vila S, Pérez-Solá V, Novo Navarro P, Gómez Simón I, Fresno González C, Camprodon Rosanas E, Bulbena Vilarrasa A. Cardiovascular and metabolic monitoring of children and adolescents on antipsychotic treatment: A cross-sectional descriptive study. Rev Psiquiatr Salud Ment (Engl Ed) 2018;11:19-26. [PMID: 27291832 DOI: 10.1016/j.rpsm.2016.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
33 Ichikawa H, Hiratani M, Yasuhara A, Tsujii N, Oshimo T, Ono H, Tadori Y. An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan. Psychiatry Clin Neurosci 2018;72:84-94. [PMID: 28941259 DOI: 10.1111/pcn.12607] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
34 Alsayouf HA, Talo H, Biddappa ML, De Los Reyes E. Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study. Children (Basel) 2021;8:318. [PMID: 33921933 DOI: 10.3390/children8050318] [Reference Citation Analysis]
35 Kaguelidou F, Holstiege J, Schink T, Bezemer I, Poluzzi E, Mazzaglia G, Pedersen L, Sturkenboom M, Trifirò G. 'Use of antipsychotics in children and adolescents: a picture from the ARITMO population-based European cohort study'. Epidemiol Psychiatr Sci 2020;29:e117. [PMID: 32308179 DOI: 10.1017/S2045796020000293] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
36 Findling RL, Landbloom RL, Mackle M, Wu X, Snow-Adami L, Chang K, Durgam S. Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial. Paediatr Drugs 2016;18:367-78. [PMID: 27461426 DOI: 10.1007/s40272-016-0184-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
37 Turkel SB, Hanft A. The pharmacologic management of delirium in children and adolescents. Paediatr Drugs 2014;16:267-74. [PMID: 24898718 DOI: 10.1007/s40272-014-0078-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
38 Simashkova NV, Makushkin EV, Ivanov MV, Balakireva EE, Kulikov AV, Koval-Zaytsev AA, Luss LA. [Models of clinical and social management of patients with autism spectrum disorders]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:13-20. [PMID: 34283524 DOI: 10.17116/jnevro202112106113] [Reference Citation Analysis]
39 Menard M, Thümmler S, Giannitelli M, Cruzel C, Bonnot O, Cohen D, Askenazy F, Boublil M, Chambry J, Charvet D, Cseterky M, Fontas E, Fourneret P, Gicquel L, Kabuth B, Leroy B, Maria F, Moceri P, Parassol-girard N, Ravis B, Raynaud J, Roche J, Rochet T. Incidence of adverse events in antipsychotic-naïve children and adolescents treated with antipsychotic drugs: Results of a multicenter naturalistic study (ETAPE). European Neuropsychopharmacology 2019;29:1397-407. [DOI: 10.1016/j.euroneuro.2019.10.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
40 Ichikawa H, Mikami K, Okada T, Yamashita Y, Ishizaki Y, Tomoda A, Ono H, Usuki C, Tadori Y. Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study. Child Psychiatry Hum Dev 2017;48:796-806. [PMID: 28004215 DOI: 10.1007/s10578-016-0704-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 11.7] [Reference Citation Analysis]
41 Lian J, Deng C. Early antipsychotic exposure affects NMDA and GABAA receptor binding in the brains of juvenile rats. Psychiatry Res 2019;273:739-45. [PMID: 31207861 DOI: 10.1016/j.psychres.2019.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
42 Muneer A. Aripiprazole in the treatment of refractory mood disorders: a case series. Clin Psychopharmacol Neurosci 2014;12:157-9. [PMID: 25191507 DOI: 10.9758/cpn.2014.12.2.157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
43 Shymko G, Grace T, Jolly N, Dobson L, Hacking D, Parmar A, Kapi P, Waters F. Weight gain and metabolic screening in young people with early psychosis on long acting injectable antipsychotic medication (aripiprazole vs paliperidone). Early Interv Psychiatry 2021;15:787-93. [PMID: 32715655 DOI: 10.1111/eip.13013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Rafaniello C, Sessa M, Bernardi FF, Pozzi M, Cheli S, Cattaneo D, Baldelli S, Molteni M, Bernardini R, Rossi F, Clementi E, Bravaccio C, Radice S, Capuano A. The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions. Pharmacogenomics J 2018;18:422-30. [PMID: 28719598 DOI: 10.1038/tpj.2017.38] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
45 Waszak PM, Zagożdżon P, Pierucka M, Kubanek A. Antipsychotic Medication Prescribing Trends in a Pediatric Population in Northern Poland 2008-2012. J Child Adolesc Psychopharmacol 2018;28:631-6. [PMID: 30048153 DOI: 10.1089/cap.2017.0154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]